Introduction {#s1}
============

Within 1 week following peroral high-dose infection with more than 50 cysts of the intracellular protozoan parasite *Toxoplasma gondii* strain ME49 susceptible mice irrespective whether harboring a murine or human gut microbiota develop acute necrotizing inflammation of the terminal ileum with lethal outcome (Heimesaat et al., [@B20]; Munoz et al., [@B40]; von Klitzing et al., [@B45],[@B47]). This CD4+ T lymphocyte dependent inflammatory condition is characterized by massive secretion of pro-inflammatory mediators such as TNF, IFN-γ, and nitric oxide, whereas IL-10 expression is upregulated as counter-regulatory measure (Liesenfeld et al., [@B34], [@B33]; Jankovic et al., [@B30]; Munoz et al., [@B40]). Given the terminal ileum as predilection site, the underlying Th1-type immunopathology, and the pronounced changes in the commensal gut microbiota composition (i.e., dysbiosis) characterized by an overgrowth of the inflamed ileal lumen with commensal *Escherichia coli* and *Bacteroides / Prevotella* species, the high-dose *T. gondii* infection model mimics key features of human inflammatory bowel diseases such as Crohn\'s disease (Liesenfeld, [@B32]; Heimesaat et al., [@B20]; Munoz et al., [@B39], [@B40], [@B38]). However, data regarding long-term intestinal and extra-intestinal sequelae of peroral murine *T. gondii* post-infection resulting in intestinal inflammation are lacking due to the fatal immunopathological course within 1 week post infection (p.i).

We have previously established a subacute and non-lethal ileitis model following peroral low-dose (i.e., one cyst) *T. gondii* ME49 strain infection (Dunay et al., [@B9]; Escher et al., [@B16]; Heimesaat et al., [@B22]). In order to further dissect the interplay between parasite, host immunity and gut microbiota (the latter mimicking human conditions) during infection-induced inflammation we had generated mice harboring a complex human gut microbiota prior ileitis induction (Bereswill et al., [@B4]; von Klitzing et al., [@B45],[@B47],[@B46],[@B48]; Escher et al., [@B16]; Heimesaat et al., [@B22],[@B25]). Within 9 days p.i. mice were suffering from T cell dependent subacute ileitis that was characterized by rather mild symptoms and mild-to-moderate ileal histopathological changes without necrosis (Escher et al., [@B16]; Heimesaat et al., [@B22]). We did, however, not follow-up mice suffering from subacute ileitis beyond day 9 p.i.

This prompted us in the present study to perform a comprehensive long-term immunopathological survey of conventional C57BL/6j mice until day 57 following ileitis induction. We here demonstrate that immunopathological sequelae of ileitis induction (i) were most severe during the early phase of peroral low-dose *T. gondii* infection (i.e., around day 10 p.i.), (ii) affected not only the terminal ileum but also the colon, (iii) were accompanied by distinct shifts in the commensal microbiota composition within the ileal lumen, and (iv) were not restricted to the intestinal tract but could also be observed in extra-intestinal and (v) strikingly, even in systemic compartments.

Materials and Methods {#s2}
=====================

Ethics Statement
----------------

Mouse experiments were performed in accordance with the European Guidelines for animal welfare (2010/63/EU). The protocols for these experiments were approved by "Landesamt für Gesundheit und Soziales," LaGeSo, Berlin (registration numbers G244/98). Clinical conditions of mice were assessed at least once daily.

Mice and *T. gondii* Infection
------------------------------

C57BL/6j mice were reared and housed under specific pathogen free (SPF) conditions in the Forschungseinrichtungen für Experimentelle Medicine (Charité---University Medicine Berlin). Conventionally colonized female mice 12 weeks of age were included into the experiments. On day (d) 0, mice were perorally subjected to low-dose *T. gondii* infection (i.e., one cyst of strain ME49 in a volume of 0.3 mL by gavage) as described recently (Heimesaat et al., [@B20], [@B22]). *T. gondii* DNA was quantitated in homogenized ileal tissue (\~1 cm^2^) as stated elsewhere (Munoz et al., [@B39]).

Sampling Procedures
-------------------

At defined time points, namely d10, d36, or d57 p.i., mice were sacrificed by isofluran inhalation (Abbott, Germany). Naive mice served as uninfected controls. Upon necropsy, cardiac blood, luminal ileal samples as well as *ex vivo* biopsies from mesenteric lymph nodes (MLN), spleen, liver, kidneys, lungs, heart, colon and ileum were obtained under sterile conditions.

Histopathology
--------------

After removal ileal *ex vivo* biopsies were immediately fixed in 5% formalin and embedded in paraffin. After hematoxylin and eosin (H&E) staining, histopathological changes were quantitatively assessed in 5 μm thin sections applying a standardized scoring system ranging from 0 to 6 as stated elsewhere (Heimesaat et al., [@B20]).

Immunohistochemistry {#s3}
====================

For *in situ* immunohistochemical analyses *ex vivo* biopsies were obtained from the ileum, colon, liver, kidneys, lungs and the heart, immediately fixed in 5% formalin and embedded in paraffin. In order to quantitatively determine apoptotic and proliferating epithelial cells, macrophages and monocytes, T lymphocytes and B lymphocytes cells, paraffin sections (5 μm) were stained with primary antibodies directed against cleaved caspase 3 (Asp175, Cell Signaling, Beverly, MA, USA, 1:200), Ki67 (TEC3, Dako, Denmark, 1:100), F4/80 (\# 14-4801, clone BM8, eBioscience, San Diego, CA, USA, 1:50), CD3 (\#N1580, Dako, 1:10), and B220 (No. 14-0452-81, eBioscience; 1:200), respectively, as described earlier (Heimesaat et al., [@B25]). Positively stained cells were then determined applying light microscopy (magnification 100 x and 400 x), and for each mouse the average number of respective positively stained cells was assessed within at least six high power fields (HPF, 0.287 mm^2^, 400 x magnification) by a blinded independent investigator. In order to provide a broader overview of the *T. gondii* induced immunopathological sequelae, representative photomicrographs of the immunohistochemically stained paraffin sections are provided with lower magnification (100 x) in the Online [Supplemental Materials](#SM1){ref-type="supplementary-material"}.

Pro- and Anti-inflammatory Mediator Detection
---------------------------------------------

Intestinal *ex vivo* biopsies were cut longitudinally, washed in phosphate buffered saline (PBS; Gibco, Life Technologies, UK), and strips of \~1 cm^2^ tissue as well as *ex vivo* biopsies derived from MLN (3 lymph nodes), liver (\~1 cm^3^), one kidney (cut longitudinally), one lung, and spleen (one third) were transferred to 24-flat-bottom well-culture plates (Nunc, Germany) containing 500 μL serum-free RPMI 1640 medium (Gibco, life technologies, UK) supplemented with penicillin (100 U/mL) and streptomycin (100 μg/mL; PAA Laboratories, Germany). After 18 h at 37°C, respective culture supernatants as well as serum samples were tested for TNF, IFN-γ, MCP-1, IL-6, IL-12p70, and IL-10 by the Mouse Inflammation Cytometric Bead Assay (CBA; BD Biosciences, Germany) on a BD FACSCanto II flow cytometer (BD Biosciences). Nitric oxide was measured by the Griess reaction as stated elsewhere (Heimesaat et al., [@B20]).

Gut Microbiota Analyses
-----------------------

DNA was extracted from ileal luminal samples as reported recently (Heimesaat et al., [@B20]; Bereswill et al., [@B5]). In brief, DNA was quantitated applying the Quant-iT PicoGreen reagent (Invitrogen, UK) and adjusted to 1 ng per μL. The total eubacterial load as well as the main bacterial groups within the murine gut microbiota such as enterobacteria, enterococci, lactobacilli, bifidobacteria, *Bacteroides / Prevotella* species, *Clostridium coccoides* group, and *Clostridium leptum* group were determined by quantitative real-time polymerase chain reaction (qRT-PCR) with species-, genera- or group-specific 16S rRNA gene primers (Tib MolBiol, Germany) as stated elsewhere (Heimesaat et al., [@B28]; Bereswill et al., [@B4]; Rausch et al., [@B41]) (expressed as numbers of 16S rRNA gene copies per ng DNA).

Statistical Analysis
--------------------

Medians and levels of significance were determined by one-way ANOVA or Kruskal-Wallis test followed by Tukey post-correction for multiple comparisons (GraphPad Prism v7, USA) as indicated. Two-sided probability (p) values ≤ 0.05 were considered significant. Experiments were reproduced three times.

Results {#s4}
=======

Intestinal Inflammatory Changes Upon Peroral Low-Dose *T. gondii* Infection
---------------------------------------------------------------------------

In order to induce subacute ileitis, conventionally colonized mice were perorally subjected to low-dose (i.e., one cyst of) *T. gondii* challenge by gavage and to a comprehensive immunopathological survey for almost 2 months p.i. Within 10 days upon infection mild-to-moderate histopathological changes of the ileal mucosa could be observed ranging from edematous mucosal blubbing, leukocytic infiltrates of the ileal mucosa and lamina propria, cell-free exudates into the small intestinal lumen, and cellular shedding (*p* \< 0.001 vs. naive; [Figure 1A](#F1){ref-type="fig"} and [Figure S1A](#SM1){ref-type="supplementary-material"}). As compared to day 10 p.i., median histopathological scores quantitatively assessing ileal mucosal damage tended to be lower at later time points, but did not reach statistical significance due to high standard deviations (n.s.; [Figure 1A](#F1){ref-type="fig"} and [Figure S1A](#SM1){ref-type="supplementary-material"}). We additionally quantitatively surveyed intestinal inflammatory responses applying *in situ* immunohistochemistry of intestinal paraffin sections. In *T. gondii* infected mice, multifold increased apoptotic ileal epithelial cell numbers could be determined at days 10 and 57 (*p* \< 0.001 and *p* \< 0.01, respectively vs. naive) with highest counts in *ex vivo* biopsies taken at day 10 p.i. (*p* \< 0.001 vs. day 36 and day 57 p.i.; [Figure 1B](#F1){ref-type="fig"} and [Figure S1B](#SM1){ref-type="supplementary-material"}). In parallel, Ki67+ ileal epithelial cells indicative for cell proliferation and regeneration counteracting *T. gondii* induced cell damage increased to a maximum at day 10 p.i. (*p* \< 0.001), declined thereafter, but were still higher as compared to those in naive control mice (*p* \< 0.001; [Figure 1C](#F1){ref-type="fig"} and [Figure S1C](#SM1){ref-type="supplementary-material"}).

![Microscopic inflammatory sequelae in the ileum over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). **(A)** Histopathological changes were quantified in H&E stained paraffin sections from ileal *ex vivo* biopsies assessing a standardized histopathological scoring system. Out of six representative high power fields (HPF, 400x magnification) per animal the average numbers of **(B)** apoptotic (casapse3+, Casp3+) and **(C)** proliferating (Ki67+) ileal epithelial cells as well as of **(D)** T lymphocytes (CD3+) and **(E)** B lymphocytes within the ileal mucosa and lamina propria were assessed in immunohistochemically stained small intestinal paraffin sections. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0001){#F1}

Given that *T. gondii* induced ileitis is highly T cell dependent (Munoz et al., [@B40]), we quantitated CD3+ T lymphocytes in the ileal mucosa and lamina propria. In fact, T cell numbers almost doubled with 10 days p.i., but declined back to naive counts thereafter (*p* \< 0.001; [Figure 1D](#F1){ref-type="fig"} and [Figure S1D](#SM1){ref-type="supplementary-material"}). In addition, *T. gondii* infected mice also displayed elevated B cell numbers in their ileal mucosa and lamina propria at day 10 p.i. (*p* \< 0.01; [Figure 1E](#F1){ref-type="fig"} and [Figure S1E](#SM1){ref-type="supplementary-material"}), but not at later time points.

We have recently observed that *T. gondii* induced immunopathological responses within the intestinal tract do not exclusively affect the terminal ileum, but also the large intestines (Escher et al., [@B16]; Heimesaat et al., [@B22]) and therefore expanded our inflammatory survey to the colon. Histopathological mucosal changes within in colonic mucosa were rather minor, however ([Figure S2A](#SM2){ref-type="supplementary-material"}), and did not reach statistical significance due to high standard deviations within respective groups (n.s.; not shown). When quantitating apoptotic cells by *in situ* immunohistochemistry, multifold increased numbers of apoptotic colonic epithelial cells could be assessed only at day 10 p.i. (*p* \< 0.001; [Figure 2A](#F2){ref-type="fig"} and [Figure S2B](#SM2){ref-type="supplementary-material"}), which also held true for T lymphocytes (*p* \< 0.001; [Figure 2C](#F2){ref-type="fig"} and [Figure S2D](#SM2){ref-type="supplementary-material"}) and B lymphocytes in the large intestinal mucosa and lamina propria (*p* \< 0.001; [Figure 2D](#F2){ref-type="fig"} and [Figure S2E](#SM2){ref-type="supplementary-material"}). Like in the ileum, elevated Ki67+ cells numbers could be observed in the colonic epithelia upon *T. gondii* infection (*p* \< 0.001; [Figure 2B](#F2){ref-type="fig"} and [Figure S2C](#SM2){ref-type="supplementary-material"}),

![Microscopic inflammatory sequelae in the colon over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six representative high power fields (HPF, 400x magnification) per animal the average numbers of **(A)** apoptotic (casapse3+, Casp3+) and **(B)** proliferating (Ki67+) colonic epithelial cells as well as of **(C)** T lymphocytes (CD3+) and **(D)** B lymphocytes within the colonic mucosa and lamina propria were assessed in immunohistochemically stained large intestinal paraffin sections. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0002){#F2}

Hence, apoptotic, proliferating and T cell as well as B cell responses within both, the small as well as the large intestines were most pronounced 10 days following peroral low-dose *T. gondii* infection.

Intestinal Inflammatory Mediator Secretion Upon Peroral Low-Dose *T. gondii* Infection
--------------------------------------------------------------------------------------

We next assessed pro-inflammatory mediator secretion in *ex vivo* biopsies derived from distinct intestinal compartments ([Figure 3](#F3){ref-type="fig"}). At day 10 p.i., increased ileal nitric oxide and IFN-γ concentrations could be measured (*p* \< 0.001; [Figures 3A,C](#F3){ref-type="fig"}), that declined to naive levels thereafter. In the colon, however, increased TNF concentrations could be observed at either time point p.i. (*p* \< 0.05-0.001; [Figure 3E](#F3){ref-type="fig"}) with maximum levels at day 10 p.i. (*p* \< 0.001; [Figure 3E](#F3){ref-type="fig"}). Alike the ileum, increased IFN-γ concentrations were measured in large intestinal *ex vivo* biopsies exclusively at day 10 p.i. (*p* \< 0.001; [Figure 3F](#F3){ref-type="fig"}), whereas elevated colonic TNF levels could be measured at days 10 and 57 p.i. (*p* \< 0.001 and *p* \< 0.05, respectively; [Figure 3E)](#SM3){ref-type="supplementary-material"}.

![Intestinal pro-inflammatory mediator secretion over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Pro-inflammatory mediators such as **(A,D,G)** nitric oxide, **(B,E,H)** TNF and **(C,F,I)** IFN-γ were measured in *ex vivo* biopsies taken from distinct intestinal compartments including the **(A--C)** ileum, **(D--F)** colon and **(G--I)** mesenteric lymph nodes (MLN) at respective time points. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0003){#F3}

We further surveyed pro-inflammatory mediator secretion in MLN draining the inflamed intestines. As early as day 10 p.i., TNF and IFN-γ concentrations had increased in the MLN (*p* \< 0.001; [Figures 3H,I](#F3){ref-type="fig"}), but declined to naive levels later-on, which also held true for nitric oxide (*p* \< 0.05--0.005; [Figure 3G](#SM3){ref-type="supplementary-material"}).

Hence, peroral low dose *T. gondii* infection was accompanied by pronounced pro-inflammatory mediator secretion in the entire intestinal tract, particularly during the early phase (i.e., the first 10 days p.i.).

Intestinal Microbiota Changes Upon Peroral Low-Dose *T. gondii* Infection
-------------------------------------------------------------------------

Given that inflammatory processes in the intestinal tract are associated with pronounced shifts in the gut microbiota composition (Heimesaat et al., [@B20], [@B23],[@B24]; Erridge et al., [@B15]; Bereswill et al., [@B4]; Fiebiger et al., [@B17]), we quantitatively surveyed changes in distinct intestinal gut bacterial groups and species applying culture-independent 16S rRNA based methods ([Figures 4A--I](#F4){ref-type="fig"}). Within 10 days p.i., enterobacteria and enterococci had increased in luminal samples taken from the inflamed ileum (*p* \< 0.001; [Figures 4B,C](#F4){ref-type="fig"}), but declined thereafter (*p* \< 0.05--0.001; [Figures 4B,C](#F4){ref-type="fig"}), whereas obligate anaerobic Gram-negative species such as *Bacteroides / Prevotella* species were slightly higher at either time point p.i. as compared to naive mice (*p* \< 0.05; [Figure 4F](#F4){ref-type="fig"}). Conversely, lactobacilli were lower in ileal samples derived from *T. gondii* infected mice (*p* \< 0.01--0.001; [Figure 4D](#F4){ref-type="fig"}), which also held true for bifidobacteria at days 36 and 57 p.i. (*p* \< 0.05--0.01; [Figure 4E](#F4){ref-type="fig"}). Converse to enterobacteria and enterococci, the obligate anaerobic *Clostridium coccoides* and *Mouse Intestinal Bacteroides* decreased to lowest levels until day 10 p.i. (*p* \< 0.05--0.005; [Figures 4G--I](#F4){ref-type="fig"}), but increased later-on (*p* \< 0.05--0.001; [Figures 4G,I](#F4){ref-type="fig"}). For *Clostridium leptum*, a trend toward lower gene numbers at day 10 p.i. as compared to naïve conditions could be observed (n.s. due to high standard deviations; [Figure 4H](#F4){ref-type="fig"}), whereas bacterial loads were higher at days 36 and 37 vs. day 10 p.i. (*p* \< 0.001 and *p* \< 0.01, respectively; [Figure 4H](#SM4){ref-type="supplementary-material"}).

![Ileal microbiota composition and parasitic loads over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). **(A)** The total eubacterial loads as well as the main gut bacterial groups (**B--I**, as indicated) and **(J)** *T. gondii* DNA were quantitated in ileal samples by culture-independent molecular methods and expressed as gene numbers per ng DNA. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0004){#F4}

Of note, increased *T. gondii* DNA could be detected in small intestinal *ex vivo* biopsies at day 10 p.i., but not later-on (*p* \< 0.001; [Figure 4J](#SM4){ref-type="supplementary-material"}).

Hence, *T. gondii* induced immunopathological sequelae observed in the ileum were accompanied by pronounced shifts in the luminal gut microbiota composition in the distal small intestines.

Extra-Intestinal Inflammatory Changes Upon Peroral Low-Dose *T. gondii* Infection
---------------------------------------------------------------------------------

We next surveyed potential *T. gondii* induced inflammatory changes in extra-intestinal compartments over time. *T. gondii* infected mice displayed elevated numbers of caspase3+ cells in their livers exclusively at day 10 p.i. (*p* \< 0.001; [Figure 5A](#F5){ref-type="fig"} and [Figure S4A](#SM4){ref-type="supplementary-material"}). In addition, hepatic F4/80+ cells had increased as early as day 10 p.i. (*p* \< 0.001), but declined to naive numbers until day 57 p.i. (*p* \< 0.001; [Figure 5B](#F5){ref-type="fig"} and [Figure S3B](#SM3){ref-type="supplementary-material"}). At either time point p.i., mice exhibited increased numbers of both, T and B lymphocytes in their livers (*p* \< 0.001; [Figures 5C,D](#F5){ref-type="fig"} and [Figures S3C,D](#SM3){ref-type="supplementary-material"}). Furthermore, *T. gondii* induced hepatic inflammatory cell responses were accompanied by enhanced secretion of pro-inflammatory mediators measured at day 10 p.i. (*p* \< 0.001 vs. naive; [Figures 6A--C](#F6){ref-type="fig"}). At day 36 p.i., hepatic anti-inflammatory IL-10 concentrations were lower as compared to those obtained at day 10 p.i. (*p* \< 0.01; [Figure 6D](#SM6){ref-type="supplementary-material"}).

![Microscopic inflammatory sequelae in the liver over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36 and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six representative high power fields (HPF, 400x magnification) per animal the average numbers of **(A)** apoptotic (casapse3+, Casp3+) and **(B)** proliferating (Ki67+) cells as well as of **(C)** T lymphocytes (CD3+) and **(D)** B lymphocytes were assessed in immunohistochemically stained hepatic paraffin sections. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0005){#F5}

![Hepatic inflammatory mediator secretion over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). **(A)** Nitric oxide, **(B)** TNF, **(C)** IFN-γ and **(D)** IL-10 concentrations were measured in *ex vivo* biopsies taken from the liver at respective time points. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0006){#F6}

Enhanced inflammatory responses upon low-dose *T. gondii* infection could also be observed in the kidneys. In fact, at day 10 following *T. gondii* infection mice exhibited multifold increased numbers of apoptotic cells in their kidneys, but not later-on ([Figure 7A](#F7){ref-type="fig"} and [Figure S4A](#SM6){ref-type="supplementary-material"}), whereas renal T cell numbers were elevated at either time point p.i. (*p* \< 0.05--0.001), but with lower counts at day 57 vs. day 10 p.i. (*p* \< 0.001; [Figure 7B](#F7){ref-type="fig"} and [Figure S4B](#SM4){ref-type="supplementary-material"}). Pathogen induced increases in renal B cell numbers could be observed rather late in the course of infection (i.e., days 36 and 57 p.i.; *p* \< 0.001; [Figure 7C](#F7){ref-type="fig"} and [Figure S4C](#SM4){ref-type="supplementary-material"}). When assessing pro-inflammatory mediator secretion in renal *ex vivo* biopsies, nitric oxide, TNF and IFN-γ increased as early as day 10 p.i. (*p* \< 0.001; [Figures 8A--C](#F8){ref-type="fig"}). Conversely, IL-10 concentrations were lower at days 10 and 36 p.i. when compared to naive mice (*p* \< 0.001; [Figure 8D](#F8){ref-type="fig"}).

![Microscopic inflammatory sequelae in the kidneys over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six representative high power fields (HPF, 400x magnification) per animal the average numbers of **(A)** apoptotic (casapse3+, Casp3+) cells, of **(B)** T lymphocytes (CD3+) and **(C)** B lymphocytes were assessed in immunohistochemically stained renal paraffin sections. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0007){#F7}

![Renal inflammatory mediator secretion over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). **(A)** Nitric oxide, **(B)** TNF, **(C)** IFN-γ, and **(D)** IL-10 concentrations were measured in *ex vivo* biopsies taken from the kidneys at respective time points. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0008){#F8}

We further expanded our inflammatory survey to the lungs. Apoptotic pulmonary cells dramatically increased until day 10 p.i. (*p* \< 0.001), but decreased back to naïve levels later-on (*p* \< 0.001; [Figure 9A](#F9){ref-type="fig"} and [Figure S5A](#SM5){ref-type="supplementary-material"}). Low-dose *T. gondii* infected mice further exhibited increased numbers of F4/80+ cells in the lungs (*p* \< 0.001) with maximum counts at day 36 p.i. ([Figure 9B](#F9){ref-type="fig"} and [Figure S5B](#SM5){ref-type="supplementary-material"}). In addition, pulmonary T lymphocytes were elevated at either time point following *T. gondii* infection (*p* \< 0.001; [Figure 9C](#F9){ref-type="fig"} and [Figure S5C](#SM5){ref-type="supplementary-material"}), whereas *T. gondii* induced increases in B lymphocytes could be assessed in the later stages of the infection (i.e., days 36 and 57 p.i.; *p* \< 0.001) with highest counts at the end of the survey; (*p* \< 0.001; [Figure 9D](#F9){ref-type="fig"} and [Figure S5D](#SM5){ref-type="supplementary-material"}).

![Microscopic inflammatory sequelae in the lungs over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six representative high power fields (HPF, 400x magnification) per animal the average numbers of **(A)** apoptotic (casapse3+, Casp3+) cells, of **(B)** macrophages and monocytes (F4/80+), of **(C)** T lymphocytes (CD3+) and **(D)** B lymphocytes were assessed in immunohistochemically stained pulmonary paraffin sections. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0009){#F9}

Interestingly, increased secretion of pro-inflammatory cytokines such as TNF and IFN-γ (*p* \< 0.001) as well as of anti-inflammatory IL-10 concentrations (*p* \< 0.05) could be exclusively determined in lungs taken at the earliest time point p.i. ([Figure 10](#F10){ref-type="fig"}).

![Pulmonal inflammatory mediator secretion over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). **(A)** TNF, **(B)** IFN-γ, and **(C)** IL-10 concentrations were measured in *ex vivo* biopsies taken from the lungs at respective time points. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0010){#F10}

Remarkably, overt *T. gondii* induced inflammatory changes could also be assessed in the heart as indicated by increased numbers of apoptotic cells at days as well as of T lymphocytes in the cardiac muscle of infected mice (*p* \< 0.01--0.001; [Figures S6A,B](#SM6){ref-type="supplementary-material"}, [S7A,B](#SM7){ref-type="supplementary-material"}), whereas highest apoptotic cell numbers could be counted at the end of the survey (*p* \< 0.05 vs. d10 p.i.; [Figures S6A](#SM6){ref-type="supplementary-material"}, [S7A)](#SM7){ref-type="supplementary-material"}. Furthermore, cardiac B cell numbers were higher on days 36 and 57 p.i. as compared to earlier time points (*p* \< 0.05--0.01; [Figures S6C](#SM6){ref-type="supplementary-material"}, [S7C](#SM7){ref-type="supplementary-material"}).

Hence, pronounced inflammatory responses following peroral low-dose *T. gondii* infection were not restricted to the intestinal tract, but could also be observed in extra-intestinal compartments.

Systemic Inflammatory Responses Upon Peroral Low-Dose *T. gondii* Infection
---------------------------------------------------------------------------

We next assessed *T. gondii* induced immunopathological responses in systemic compartments. Whereas, increased pro-inflammatory cytokines such as IFN-γ and IL-12p70 could be measured in splenic *ex vivo* biopsies at day 10 p.i. only (*p* \< 0.001; [Figures 11A,B](#F11){ref-type="fig"}), anti-inflammatory IL-10 levels were deprived in the spleen at either time point p.i. (*p* \< 0.001; [Figure 11C](#F11){ref-type="fig"}). Strikingly, elevated TNF, IFN-γ, MCP-1 and IL-6 concentrations were obtained in serum samples taken from *T. gondii* infected mice at day 10 p.i. (*p* \< 0.001), but declined back to baseline levels later-on (*p* \< 0.001; [Figures 12A--D](#F12){ref-type="fig"}). In case of IL-10, slightly increased serum concentrations could be exclusively observed at day 36 p.i. (*p* \< 0.05; [Figure 12E](#F12){ref-type="fig"}).

![Splenic inflammatory mediator secretion over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). **(A)** IFN-γ, **(B)** IL-12p70, and **(C)** IL-10 concentrations were measured in *ex vivo* biopsies taken from the spleen at respective time points. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0011){#F11}

![Systemic inflammatory mediator secretion over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). **(A)** TNF, **(B)** IFN-γ, **(C)** MCP-1, **(D)** IL-6 and **(E)** IL-10 concentrations were measured in serum samples taken at respective time points. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.](fcimb-09-00098-g0012){#F12}

Hence, inflammatory responses following peroral low-dose *T. gondii* infection could be assessed even in systemic compartments that were most pronounced within the first 10 days p.i.

Discussion {#s5}
==========

The peroral high-dose *T. gondii* infection mouse model has been proven to be well-suited for investigating the underlying molecular mechanism of pathogen-host interactions and subsequently induced acute small intestinal inflammation (McLeod et al., [@B35],[@B36]; Liesenfeld et al., [@B34], [@B33]; Liesenfeld, [@B32]; Vossenkamper et al., [@B49]; Heimesaat et al., [@B20]; Munoz et al., [@B39], [@B40], [@B38]). In this context one needs to take into consideration, however, that the severity of *T. gondii* induced ileitis does not meet a linear causal relationship to the amount of parasite cysts the mice had been challenged with. In fact, it is rather a critical threshold of cyst number that needs to be reached to induce the full-blown inflammatory scenario, further depending on the parasitic strain and the genetic background and sex of the murine host (Liesenfeld et al., [@B33]; Munoz et al., [@B40]; Heimesaat et al., [@B22]). Given the lethal outcome within 7--10 days, information regarding long-term sequelae of *T. gondii* ME49 strain induced intestinal inflammation are scarce, however.

We have established a far less acute *T. gondii* induced ileitis model by decreasing the numbers of the perorally applied parasitic infection dose from \>50 cysts to only one cyst per recipient mouse (Dunay et al., [@B9]; Heimesaat et al., [@B22]). One can imagine that an accidental increase in the parasitic inoculum may yield an unwantedly more severe ileitis with fatal outcome within \<2 weeks. Besides the critically low infection dose, distinct host characteristics such as age and sex of the infected mice might impact the severity of induced immunopathology (Liesenfeld et al., [@B33]; Dunay et al., [@B9]; Munoz et al., [@B40]; Heimesaat et al., [@B22]). Hence, the reproducibility and reliability of the peoral low-dose *T. gondii* infection model critically depends on highly standardized conditions and the experiences of the handling researchers (Heimesaat et al., [@B22]). However, with the subacute ileitis model at hand, we are now able to survey the interactions within the triangle relationship ("ménage-à-trois") of the parasitic pathogen, the host immunity and the commensal gut microbiota during intestinal inflammation for 2 months (like in the present study) or even longer. In our very recent low-dose *T. gondii* infection studies mice were sacrificed at day 9 p.i. (Escher et al., [@B16]; Heimesaat et al., [@B22]).

In our actual immunopathological survey for more than 8 weeks, perorally low-dose *T. gondii* infected mice developed subacute ileitis within 10 days that was characterized by a non-lethal outcome, rather mild symptoms and mild-to-moderate histopathological changes of the ileal mucosa, but no intestinal necrosis at all. Furthermore, ileal epithelial apoptosis was accompanied by a concomitant increased abundance of proliferating/regenerating epithelial cells in the terminal ileum counteracting the inflammatory damage. Remarkably, *T. gondii* induced inflammatory changes did not exclusively affect the terminal ileum which is considered the predilection site following peroral high-dose *T. gondii* infection (Liesenfeld et al., [@B34]; Munoz et al., [@B40]), but also the large intestinal tract given that numbers of apoptotic epithelial cells as well as of T and B lymphocytes in the mucosa and lamina propria of both, the ileum and the colon were highest at day 10 post-infection, but declined thereafter. These inflammatory cellular responses were accompanied by enhanced pro-inflammatory mediator secretion in ileum, colon and mesenteric lymph nodes that was also most pronounced during the early phase of infection. In support, in our previous acute ileitis studies in (with respect to their gut microbiota) "humanized" mice we could demonstrate the colonic co-affection upon peroral high-dose *T. gondii* infection (von Klitzing et al., [@B45],[@B47]). Furthermore, Suzuki and colleagues reported inflammatory changes within the large intestines following peroral infection of IL-10^−/−^ mice with 20 cysts of the ME49 strain (Suzuki et al., [@B43]).

Remarkably, both peroral high-dose and low-dose *T. gondii* infection resulted in pro-inflammatory sequelae that were not restricted to the intestinal tract, but could also be observed in extra-intestinal and even systemic compartments as shown in our previous reports (von Klitzing et al., [@B45],[@B47]; Heimesaat et al., [@B22],[@B25]) and actual study. Overall, *T. gondii* induced and T cell driven pro-inflammatory immune responses were observed in extra-intestinal organs such as liver, kidneys, lungs, and heart during the entire observation period, but were overall most pronounced during the early phase (i.e., around day 10 p.i.). Depending on respective parasitic infection (i.e., amount and strain of cysts, application via the peroral vs. intraperitoneal route) of mice with a defined genetic background, sampling and detection techniques varying information regarding extra-intestinal parasitic infection are available in the literature. For instance, in one study exclusively assessing the parasitic dissemination following peroral infection with 20 cysts of the avirulent *T. gondii* C strain, parasitic loads had rapidly increased in the lungs until days 7 to 10 and resolved until day 50 p.i. (Derouin and Garin, [@B7]). Compared to pulmonary parasitic detection, parasitemia was rather delayed during the acute phase of infection (i.e., first 7 days p.i.), whereas low-level parasitemia was shown to occur transiently later-on (Derouin and Garin, [@B7]). In another infection study, *T. gondii* could be detected in liver and lungs of mice as early as 7-10 days following peroral challenge with 20 cysts of the avirulent C strain (Sumyuen et al., [@B42]). Dubey reported parasitemia within 24 h post peroral infection and parasitic invasion of extra-intestinal organs including liver, lungs, kidneys, skeletal and heart muscle between days 11 and 15 p.i. (Dubey, [@B8]). In these studies, however, no further information regarding immunopathological sequelae within infected compartments are available. Following challenge of C57BL/6 mice with 10 cysts of the ME49 strain via the intraperitoneal route, Liesenfeld and colleagues reported rather mild infiltration of lungs with inflammatory mononuclear cells within 7 days p.i., whereas no inflammatory foci could be assessed in other organs such as the heart or the large intestines (Liesenfeld et al., [@B34]).

In our present low-dose *T. gondii* infection study, parasitic DNA were detectable only in ileal *ex vivo* biopsies taken at day 10 p.i., but were below the detection limit in any other intestinal or extra-intestinal *ex vivo* biopsies taken during the observation period further underlining that the observed inflammatory changes are rather due to the immunological responses of the initial *T. gondii* challenge with one single cyst only. One needs to take into consideration that the (parasitic) pathogen does not necessarily need to be permanently in the infected body compartment in order to induce inflammatory sequelae. It is rather the initial hit set by the pathogen to the host subsequently tipping the balance toward immunopathology (Alutis et al., [@B1]; Heimesaat et al., [@B26],[@B27],[@B19]; Grunau et al., [@B18]).

It is well known that the fine-tuned interactions between the complex intestinal bacterial ecosystem and the host are critical for immune homeostasis, cell physiology and resistance to morbidities (Ekmekciu et al., [@B12]). Hence, disturbances in the orchestrated commensal gut microbiota composition are associated with the development and outcome of immunopathological diseases including gastrointestinal inflammation (Heimesaat et al., [@B20]; Erridge et al., [@B15]; Bereswill et al., [@B4]; Fiebiger et al., [@B17]; Ekmekciu et al., [@B12]). Our culture-independent survey of the gut bacterial changes during low-dose *T. gondii* infection revealed that until day 10 p.i. (when the severity of induced ileitis was maximum) Gram-negative bacterial commensals such as enterobacteria including *E. coli* had increased in the inflamed ileal lumen, whereas conversely, Gram-positive lactobacilli and clostridia as well as *Mouse Intestinal Bacteroides* had decreased. These observations are well in line with results derived from our lethal high-dose *T. gondii* infection studies given that ileitis development was accompanied by dramatic shifts in the ileal microbiota compositions toward an overgrowth with enterobacterial species, whereas bacterial commensal diversity was reduced and particularly lactobacilli and clostridia were virtually undetectable (Heimesaat et al., [@B20], [@B23]; Erridge et al., [@B15]). *T. gondii* induced ileitis was further aggravated by Toll-like receptor (TLR)−4 dependent signaling of lipopolysaccharide derived from the cell walls of the overgrowing Gram-negative species (Heimesaat et al., [@B23]; Erridge et al., [@B15]). During the chronic phase of low-dose *T. gondii* infection (i.e., at days 36 and 57 p.i.), mice harbored fewer bifidobacteria but also lactobacilli in the small intestines as compared to uninfected controls. Particularly bifidobacteria and lactobacilli are considered "health-beneficial" commensals with immuno-modulatory properties and sharing important functions during immune homeostasis (Bereswill et al., [@B2]; Ekmekciu et al., [@B13],[@B14]; Heimesaat et al., [@B29]). Dysbiosis with deprived intestinal bifidobacterial loads has been shown to be associated with celiac disease, irritable bowel syndrome, inflammatory bowel disease (IBD) and atopic diseases, for instance (Tojo et al., [@B44]). Furthermore, acute ileitis was more pronounced in high-dose *T. gondii* infected conventional mice that were gene deficient for either TLR-9 or nucleotide-binding oligomerization domain (NOD) 2 and were both lacking intestinal bifidobacterial commensals (Bereswill et al., [@B5]; Heimesaat et al., [@B21]).

The murine low-dose *T. gondii* infection model has most commonly been used in order to investigate parasitic inflammation of the central nervous system given that upon intraperitoneal challenge with \<10 *T. gondii* cysts of the ME49 strain susceptible mice develop chronic cerebral inflammation (Dunay et al., [@B10]; Biswas et al., [@B6]; Mohle et al., [@B37]; Lang et al., [@B31]; Dusedau et al., [@B11]). However, for investigating subacute/chronic intestinal and extra-intestinal (besides neurological) immunopathological changes the low-dose infection model has only been applied in single studies so far (Dunay et al., [@B9]; Escher et al., [@B16]; Heimesaat et al., [@B22]).

In conclusion, the here provided long-term kinetic survey of immunopathological sequalae in intestinal, extra-intestinal and systemic compartments following peroral low-dose *T. gondii* infection provides valuable corner stones for a better understanding of the complex interactions within the triangle relationship of (parasitic) pathogens, the host immunity and the commensal gut microbiota during subacute and chronic intestinal inflammation. Furthermore, the low-dose *T. gondii* infection model may be applied as valuable gut inflammation model in future pre-clinical studies in order to test potential treatment options for intestinal inflammatory conditions in humans (Bereswill et al., [@B3]).
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Representative photomicrographs illustrating inflammatory changes and distinct immune cell populations in the ileum over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N) mice served as uninfected controls. Representative photomicrographs taken from the ileum illustrate **(A)** histopathological changes (H&E staining) and **(B)** apoptotic (caspase3+, Casp3+) cells, **(C)** proliferating (Ki67+) cells, **(D)** T lymphocytes (CD3+), and **(E)** B lymphocytes (B220+) in immunohistochemically stained paraffin sections at respective time points (100 x magnification, scale bar 100 μm).
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###### 

Representative photomicrographs illustrating inflammatory changes and distinct immune cell populations in the colon over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N) mice served as uninfected controls. Representative photomicrographs taken from the colon illustrate **(A)** histopathological changes (H&E staining) and **(B)** apoptotic (caspase3+, Casp3+) cells, **(C)** proliferating (Ki67+) cells, **(D)** T lymphocytes (CD3+), and **(E)** B lymphocytes (B220+) in immunohistochemically stained paraffin sections at respective time points (100 x magnification, scale bar 100 μm).
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Representative photomicrographs illustrating inflammatory changes and distinct immune cell populations in the liver over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N) mice served as uninfected controls. Representative photomicrographs taken from the liver illustrate **(A)** apoptotic (caspase3+, Casp3+) cells, **(B)** macrophages/monocytes (F4/80+), **(C)** T lymphocytes (CD3+), and **(D)** B lymphocytes (B220+) in immunohistochemically stained paraffin sections at respective time points (100 x magnification, scale bar 100 μm).
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Representative photomicrographs illustrating inflammatory changes and distinct immune cell populations in the kidneys over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N) mice served as uninfected controls. Representative photomicrographs taken from the kidneys illustrate **(A)** apoptotic (caspase3+, Casp3+) cells, **(B)** T lymphocytes (CD3+), and **(C)** B lymphocytes (B220+) in immunohistochemically stained paraffin sections at respective time points (100 x magnification, scale bar 100 μm).
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Representative photomicrographs illustrating inflammatory changes and distinct immune cell populations in the lungs over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N) mice served as uninfected controls. Representative photomicrographs taken from the lungs illustrate **(A)** apoptotic (caspase3+, Casp3+) cells, **(B)** macrophages/monocytes (F4/80+), **(C)** T lymphocytes (CD3+), and **(D)** B lymphocytes (B220+) in immunohistochemically stained paraffin sections at respective time points (100 x magnification, scale bar 100 μm).
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###### 

Microscopic inflammatory sequelae in the heart muscle over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.; closed circles). Naive (N) mice served as uninfected controls (open circles). Out of six representative high power fields (HPF, 400x magnification) per animal the average numbers of **(A)** apoptotic (casapse3+, Casp3+) cells, of **(B)** T lymphocytes (CD3+) and **(C)** B lymphocytes were assessed in immunohistochemically stained cardiac paraffin sections. Medians (black bars), levels of significance (*p*-values) as determined by one-way ANOVA test followed by Tukey post-correction for multiple comparisons and numbers of analyzed mice (in parentheses) are indicated. Data were pooled from four independent experiments.
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Representative photomicrographs illustrating inflammatory changes and distinct immune cell populations in the heart over time following peroral low-dose *T. gondii* infection. Mice were perorally infected with one cyst of *T. gondii* on day 0 and surveyed at days (d) 10, 36, and 57 post-infection (p.i.). Naive (N) mice served as uninfected controls. Representative photomicrographs taken from the heart illustrate **(A)** apoptotic (caspase3+, Casp3+) cells, **(B)** T lymphocytes (CD3+), and **(C)** B lymphocytes (B220+) in immunohistochemically stained paraffin sections at respective time points (100 x magnification, scale bar 100 μm).
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